CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Kontafarma China Holdings Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Kontafarma China Holdings Ltd
9th Floor, Allied Kajima Building
138 Gloucester Road, Wanchai
Phone: +852 27316500p:+852 27316500 Hong Kong Ticker: 13121312
Business Summary
Kontafarma China Holdings Ltd, formely Tongfang Kontafarma Holdings Ltd, is an investment holding company principally engaged in pharmaceutical business. The Company operates its business through two business segments. The Pharmaceutical Business segment is engaged in the manufacture and sale of prescription drugs, including chemical drugs and prescribed traditional Chinese medicines, and laboratory related products. The Fitness Business is segment is engaged in the operation of fitness centers, the provision of consultation services for fitness and health activities, as well as the operation of the franchise business for royalty fee income.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202412/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
7997 Membership sports and recreation clubs
6719 Offices of holding companies, not elsewhere classified
5912 Drug stores and proprietary stores
3826 Laboratory analytical instruments
3241 Cement, hydraulic

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Executive Chairman of the Board, President FeifeiWang 37 6/7/2024 6/7/2024
Chief Operating Officer JieZhang 39 6/7/2024 9/3/2020
Vice President, Executive Director LinnaQiao 33 6/7/2024 6/7/2024
7 additional Officers and Directors records available in full report.

Business Names
Business Name
1312
AII-cement Limited
AII-Shanghai Limited
6 additional Business Names available in full report.

General Information
Number of Employees: 717 (As of 6/30/2024)
Outstanding Shares: 5,588,571,777 (As of 6/30/2024)
Stock Exchange: HKG
Fax Number: +852 27316599


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024